perfluorohexyloctane ophthalmic (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Dry Eye Disease

Pending FDA approval for dry eye disease associated with Meibomian gland dysfunction

Next:

Pharmacology

Mechanism of Action

Prevents excessive tear evaporation by stabilizing the lipid layer thickness and restores tear film balance

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.